Is Exercise Stress Testing a Cost-Saving Strategy For Risk Assessment of Pediatric Wolff-Parkinson-White Syndrome Patients?

References

1. ↵
   1. Al-Khatib S. M.,
   2. Pritchet E. L.

   (1999) Clinical features of Wolff-Parkinson-White syndrome. Am Heart J 138(3 Part 1):403–413, pmid:10467188.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Wellens H. J.,
   2. Rodriguez L. M.,
   3. Timmermans C.,
   4. Smeets J. P.

   (1997) The asymptomatic patient with Wolff-Parkinson-White electrocardiogram. PACE 20:2082–2086, pmid:9272514.

   OpenUrlCrossRefPubMed
3. ↵
   1. Conti C. R.

   (2001) What happened to the Wolff-Parkinson-White syndrome? Clin Cardiol 24:531–532, pmid:11501603.

   OpenUrlPubMed
4. ↵
   1. Munger T. M.,
   2. Packer D. L.,
   3. Hammil S. C.

   (1993) A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953–1989. Circulation 87(3):866–873, pmid:8443907.

   OpenUrlAbstract/FREE Full Text
5. ↵
   1. Perry J.

   (1998) Supraventricular tachycardia, 2059–2101, In: Garson A Jr, Bricker JT, Fisher DJ, Neish SR (eds). Science and Practice of Pediatric Cardiology, Baltimore: Williams & Wilkins.
6. ↵
   1. Bromberg B. I.,
   2. Lindsay B. D.,
   3. Cain M. E.,
   4. Cox J. L.

   (1996) Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 27(3):690–695, pmid:8606283.

   OpenUrlFREE Full Text
7. ↵
   1. Klein G. J.,
   2. Bashore T. M.,
   3. Sellers T. D.,
   4. Pritchett E. L.,
   5. Smith W. M.,
   6. Gallagher J. J.

   (1979) Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301:1080–1085, pmid:492252.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. Deal B. J.,
   2. MacDonald D.,
   3. Beerman L.

   (1995) Cardiac arrest in young patients with Wolff-Parkinson-White syndrome (Abstract). PACE 18 (Pt II):815.

   OpenUrl
9. 1. Gaita F.,
   2. Giustetto C.,
   3. Riccardi R.,
   4. Mangiardi L.,
   5. Brusca A.

   (1989) Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol 64:487–490, pmid:2773792.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    1. Bricker J. T.,
    2. Porter C. J.,
    3. Garson A. Jr.

    (1985) Exercise testing in children with Wolff-Parkinson-White syndrome. Am J Cardiol 55:1001–1004, pmid:3984857.

    OpenUrlCrossRefPubMedWeb of Science
11. 1. Sharma A. D.,
    2. Yee R.,
    3. Guiraudon G.,
    4. Klein G. J.

    (1987) Sensitivity and specificity of invasive and non-invasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 10:373–381, pmid:3598007.

    OpenUrlFREE Full Text
12. 1. Daubert C.,
    2. Ollitraut J.,
    3. Descaves C.,
    4. Mabo P.,
    5. Ritter P.,
    6. Gouffault J.

    (1988) Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff-Parkinson-White syndrome. PACE 11:1130–1138, pmid:2459665.

    OpenUrlCrossRefPubMed